The effect of microsphere degradation rate on the efficacy of polymeric microspheres as bulking agents: An 18-month follow-up study

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 80, Issue 1, 2007, Pages 253-259

  Kang, Sun Woong ^a   Cho, Eui Ri ^a   Jeon, Oju ^a   Kim, Byung Soo ^a  

^a Hanyang University   (South Korea)

Author keywords

Biodegradation; Degradation; Polymer; Urology

Indexed keywords

BIODEGRADATION; CELLS; TISSUE; UROLOGY;

BULKING AGENTS; LYMPHOCYTES; VOLUME CONSERVATION;

POLYMERS;

BULKING AGENT; MICROSPHERE; POLYGLACTIN; POLYLACTIC ACID; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; CELL MIGRATION; FOLLOW UP; HISTOLOGY; HOST CELL; HYBRID TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INJECTION THERAPY; LYMPHOCYTE MIGRATION; MALE; MASS; MATERIALS TESTING; MOLECULAR WEIGHT; MOUSE; NONHUMAN; TISSUE GROWTH; TISSUE STRUCTURE; URINE INCONTINENCE; VESICOURETERAL REFLUX; VOLUME STABILITY;

ANIMALS; CELL MOVEMENT; FOREIGN-BODY REACTION; INFLAMMATION; LACTIC ACID; LYMPHOCYTES; MATERIALS TESTING; MICE; MICE, INBRED ICR; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; TIME FACTORS;

EID: 33845948505     PISSN: 00219304     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30591     Document Type: Article

References (48)

1. Joyner BD, Atala A. Endoscopic substances for the treatment of vesicoureteral reflux. Urology 1997;50:489-494.
2. Kershen RT, Atala A. New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol Clin North Am 1999;26:81-94.
3. Capozza N, Patricolo M, Lais A, Matarazzo E, Caione P. Endoscopic treatment of vesico-ureteral reflux: Twelve years' experience. Urol Int 2001;67:228-231.
4. Kim BS, Baez CE, Atala A. Biomaterials for tissue engineering. World J Urol 2000;18:2-9.
5. Kerrebroeck PV, Meulen FT, Farrelly E, Larsson G, Edwall L, Fianu-Jonasson A. Treatment of stress urinary incontinence: Recent developments in the role of urethral injection. Urol Res 2003;30:356-362.
6. Kershen RT, Fefer SD, Atala A. Tissue-engineered therapies for the treatment of urinary incontinence and vesicoureteral reflux. World J Urol 2000;18:51-55.
7. O'Donnell B, Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J 1984;289:7-9.
8. Politano VA. Periurethral polytetrafluoroethylene injection for urinary incontinence. J Urol 1982;127:439-442.
9. DeLustro F, Smith ST, Sundsmo J, Salem G, Kincaid S, Ellingsworth L. Reaction to injectable collagen: Results in animal models and clinical use. Plast Reconstr Surg 1987;79:581-594.
10. Leonard MP, Canning DA, Peters CA, Gearhart JP, Jeffs RD. Endoscopic injection of glutaraldehyde cross-linked bovine dermal collagen for correction of vesicoureteral reflux. J Urol 1991;145:115-119.
11. Inoue K, Nakamoto T, Usui A, Usui T. Endoscopic subureteral glutaraldehyde cross-linked collagen injection for the treatment of secondary vesicoureteral reflux: Comparison with primary vesicoureteral reflux in adults. J Urol 2000;164:336-339.
12. Bent AE, Foote J, Siegel S, Faerber G, Chao R, Gormley EA. Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol 2001;166:1354-1357.
13. Herz D, Hafez A, Bagli D, Capolicchio G, McLorie G, Khoury A. Efficacy of endoscopic subureteral polydimethylsiloxane injection for treatment of vesicoureteral reflux in chirdren: A North American clinical report. J Urol 2001;166:1880-1886.
14. Oswald J, Riccabona M, Lusuardi L, Bartsch G, Radmayr C. Prospective comparison and 1-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology 2002;60:894-898.
15. Al-Hunayan AA, Kehinde EO, Elsalam MA, Al-Mukhtar RS. Outcome of endoscopic treatment for vesicoureteral reflux in children using polydimethylsiloxane. J Urol 2002;168:2181-2183.
16. Aboutaleb H, Bolduc S, Khoury AE, Upadhyay J, Bagli DJ, Farhat W. Polydimethylsiloxane injection versus open surgery for the treatment of vesicoureteral reflux in complete duplex system. J Urol 2003;170:1563-1565.
17. Lemperle G, Gauthier-Hazan N, Lemperle M. PMMA-microspheres (Artecoll) for long-lasting correction of wrinkles: Refinements and statistical results. Aesthetic Plast Surg 1998;22:356-365.
18. Lemperle G, Gauthier-Hazan N, Lemperle M. PMMA microspheres (Artecoll) for skin and soft-tissue augmentation. Part 2: Clinical investigations. Plast Reconstr Surg 1995;96:627-634.
19. Pollack SV. Some new injectable dermal filler materials: Hylaform, Restylane, and Artecoll. J Cutan Med Surg 1999;3:27-35.
20. Lee PE, Kung RC, Drutz HP. Periurethral autologous fat injection as treatment for female stress urinary incontinence: A randomized double-blind controlled trial. J Urol 2001;165:153-158.
21. Trockman BA, Leach GE. Surgical treatment of intrinsic urethral dysfunction: Injectables (fat). Urol Clin North Am 1995;22:665-671.
22. Malizia AA, Reiman HM, Myers RP, Sande JR, Barham SS, Benson RC, Dewanjee MK, Utz WJ. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 1984;251:3277-3281.
23. Claes H, Stroobants D, Van Meerbeek J, Verbeken E, Knockaert D, Baert L. Pulmonary migration following periurethral polytetrafluoroethylene injection for urinary incontinence. J Urol 1989;142:821-822.
24. Aaronson IA, Rames RA, Greene WB, Walsh LG, Hasal UA, Garen PD. Endoscopic treatment of reflux: Migration of polytetrafluoroethylene into the lungs and brain. Eur Urol 1993;23:394-399.
25. Aragona F, D'Urso L, Scremin E, Salmaso R, Glazel GP. Polytetrafluoroethylene giant granuloma and adenopathy: Long-term complications following subureteral polytetrafluoroethylene injection for the treatment of vesicoureteral reflux in children. J Urol 1997;158:1539-1542.
26. Haferkamp A, Contractor H, Mohring K, Staehler G, Dorsam J. Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long-term follow-up. Urology 2000;55:759-763.
27. Block CA, Cooper CS, Hawtrey CE. Long-term efficacy of periurethral collagen injection for the treatment of urinary incontinence secondary to myelomeningocele. J Urol 2003;169:327-329.
28. Leonard MP, Decter A, Hills K, Mix LW. Endoscopic subureteral collagen injection: Are immunological concerns justified? J Urol 1998;160:1012-1016.
29. Achauer BM. A serious complication following medical-grade silicone injection of the face. Plast Reconstr Surg 1983;71:251-254.
30. Wang J, Shih TT, Chang KJ, Li YW. Silicone migration from silicone-injected breasts: Magnetic resonance images. Ann Plast Surg 2002;48:617-621.
31. Puri P, Chertin B, Velayudham M, Dass L, Colhoun E. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic acid copolymer: Preliminary results. J Urol 2003;170:1541-1544.
32. Lackgren G, Wahlin N, Skoldenberg E, Neveus T, Stenberg A. Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer is effective in either double ureters or a small kidney. J Urol 2003;170:1551-1555.
33. Stenberg A, Larsson E, Lackgren G. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: Histological findings. J Urol 2003;169:1109-1113.
34. Cho ER, Kang SW, Kim BS. Poly(lactic-co-glycolic acid) microspheres as a potential bulking agent for urological injection therapy: Preliminary results. J Biomed Mater Res B 2005;72:166-172.
35. Kang SW, Cho ER, Kim BS. PLGA microspheres in hyaluronic acid gel as a potential bulking agent for urologic and dermatologic injection therapies. J Microbiol Biotechnol 2005;15:510-518.
36. Cho ER, Kang SW, Park HJ, Cho YS, Lee YS, Kim JC, Kim BS. Submucosal injection of poly(lactic-co-glycolic acid) microspheres in rabbit bladder as a potential treatment for urinary incontinence and vesicoureteral reflux: Preliminary results. J Biomater Sci Polym Ed 2005;16:1109-1120.
37. Lu L, Peter SJ, Lyman MD, Lai HL, Leite SM, Tamada JA, Uyama S, Vacanti JP, Langer R, Mikos AG. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials 2000;21:1837-1845.
38. Lu L, Garcia CA, Mikos AG. In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. J Biomed Mater Res 1999;46:236-244.
39. Gilding DK. Biodegradable polymers. In: Williams DF, editor. Biocompatibility of Clinical Implant Materials. Boca Raton, FL: CRC; 1981. pp 209-232.
40. Manna F, Dentini M, Desideri P, Pita OD, Mortilla E, Maras B. Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (Hylaform ® from rooster combs and Restylane ® from Streptococcus) used for soft tissue augmentation. J Eur Acad Dermatol Venereol 1999;13:183-192.
41. Chen AL, Desai P, Adler EM, Di Cesare PE. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: A report of six cases. J Bone Joint Surg Am 2002;84:1142-1147.
42. Friedman PM, Mafong EA, Kauvar ANB, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002;28:491-494.
43. Thomson RC, Wake MC, Yaszemski MJ, Mikos AG. Biodegradable polymer scaffolds to regenerate organs. Adv Polym Sci 1995;122:245-274.
44. Food and Drug Administration (USA). Workshop on innovative systems for delivery of drugs and biologics: Scientific, clinical, and regulatory challenges, FDA, Bethesda, MD, 2003. Available at www.fda.gov.
45. Haferkamp A, Mohring K, Staehler G, Gerner HJ, Dorsam J. Long-term efficacy of subureteral collagen injection for endoscopic treatment of vesicoureteral reflux in neurogenic bladder cases. J Urol 2000;163:274-277.
46. Sung HJ, Meredith C, Johnson C, Galis ZS. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 2004;25:5735-5742.
47. Burke PA. Determination of internal pH in PLGA microspheres using 31P NMR spectroscopy. Int Symp Control Release Bioactive Mater 1996;23:133-134.
48. Zhu G, Mallery SR, Schwendeman SP. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Nat Biotechnol 2000;18:52-57.